DoW Neurofibromatosis Investigator-Initiated Research Award
The summary for the DoW Neurofibromatosis Investigator-Initiated Research Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Defense Health Agency Contracting Activity - DHACA, which is the U.S. government agency offering this grant.
DoW Neurofibromatosis Investigator-Initiated Research Award: Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Investigator-Initiated Research Award (IIRA) supports high-impact research that addresses a critical need and has the potential to make important contributions to the field of neurofibromatosis disorders or advance patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.Distinctive Features: This award mechanism offers two funding levels based on participation in two optional features:• Open Science Initiative: Catalyzes research for neurofibromatosis through early access to data and data sharing within the neurofibromatosis community.• Optional Qualified Collaborator: Encourages collaborative research between basic scientists and clinical researchers, and between academic and biotechnology scientists.The funding levels are defined as follows:• Level 1: Applications without an optional feature.• Level 2: Applications including one of the optional features.
| Federal Grant Title: | DoW Neurofibromatosis Investigator-Initiated Research Award |
| Federal Agency Name: | Defense Health Agency Contracting Activity - DHACA (DOD-AMRAA) |
| Grant Categories: | Science and Technology and other Research and Development |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | HT942526NFRPIIRA |
| Type of Funding: | Grant |
| CFDA Numbers: | 12.420 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | September 22nd, 2026 |
| Original Application Deadline: | September 22nd, 2026 |
| Posted Date: | June 25th, 2026 |
| Creation Date: | June 25th, 2026 |
| Archive Date: | October 22nd, 2026 |
| Total Program Funding: | $6,040,000 |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | 7 |
| Cost Sharing or Matching: | No |
| Last Updated: | June 25th, 2026 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- eBRAP Help Desk
Phone: 301-682-5507
Email: [email protected]
eBRAP Help Desk - Similar Government Grants
- • DoW Neurofibromatosis Exploration-Hypothesis Development Award
- • DoW Neurofibromatosis Research Academy - Scholar Award
- • DoW Neurofibromatosis Synergistic Idea Award
- • DOW Combat Readiness - Medical Research Program Translational Research Award
- • DoW Neurofibromatosis Research Academy - Leadership Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Defense Health Agency Contracting Activity - DHACA
- • DoW Neurofibromatosis Exploration-Hypothesis Development Award
- • DoW Neurofibromatosis Research Academy - Scholar Award
- • DoW Neurofibromatosis Synergistic Idea Award
